Is CTEV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CTEV. It does not provide personalized investment advice.

CTEV (Claritev Corporation) Stock Analysis - Financials

Claritev Corporation (CTEV) is a publicly traded Healthcare sector company. As of August 26, 2026, CTEV trades at $37.54 with a market cap of $619.94M and a P/E ratio of -2.17. CTEV moved -0.43% today. Year to date, CTEV is +11.07%; over the trailing twelve months it is -47.44%. Its 52-week range spans $11.50 to $74.07. Analyst consensus is strong buy with an average price target of $45.83. Rallies surfaces CTEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CTEV's key financials?

CTEV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTEV recently traded at $37.54. Market cap is $619.94M. P/E ratio is -2.17. Revenue is $965.41M.

CTEV Key Metrics

Key financial metrics for CTEV
Metric	Value
Price	$37.54
Market Cap	$619.94M
P/E Ratio	-2.17
EPS	$-17.30
Dividend Yield	0.00%
52-Week High	$74.07
52-Week Low	$11.50
Volume	39.57K
Avg Volume	0
Revenue (TTM)	$965.41M
Net Income	$-284.28M
Gross Margin	0.00%

CTEV Analyst Consensus

6 analysts cover CTEV: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.83.

Common questions about CTEV

What are CTEV's key financials?: CTEV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTEV recently traded at $37.54. Market cap is $619.94M. P/E ratio is -2.17. Revenue is $965.41M.
Is CTEV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CTEV. It does not provide personalized investment advice.